The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sat., Jan. 20, 1:36 AM

Slide #1. UroGen Pharma Ltd. Secondary Offering

Company: UroGen Pharma Ltd. (NASDAQ:URGN)
Date announced: 1/18/2018
Shares Offered: 1,463,414
Date of Pricing: 1/18/2018
Price Per Share: $41.00
Secondary Offering Details: UroGen Pharma Ltd. (Nasdaq:URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, with a focus on uro-oncology, today announced the pricing of its public offering of 1,463,414 ordinary shares, at a public offering price of $41.00 per share for gross proceeds of approximately $60.0 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 219,512 ordinary shares at the public offering price, less the underwriting discounts and commissions. All ordinary shares sold in this offering are being offered by the Company. The offering is expected to close on January 23, 2018, subject to customary closing conditions.

UroGen Pharma is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. Co.'s lead product candidates, MitoGel and VesiGel are formulations of the chemotherapy drug Mitomycin C, a generic drug which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Co. is developing its product candidates as chemoablation agents, which are designed to remove tumors by non-surgical means, to treat several forms of non-muscle invasive urothelial cancer.
Open the URGN Page at The Online Investor »

Company Name:  UroGen Pharma Ltd
Website:  www.urogen.com
Sector:  Drugs & Pharmaceuticals
Number of ETFs Holding URGN:  1
Total Market Value Held by ETFs:  $117902
Total Market Capitalization:  $474.00M
% of Market Cap. Held by ETFs:  0.02%
 

Open the URGN Page at The Online Investor (in a new window) »

List of Secondary Stock Offerings in this Slideshow:

1/9/2018:
Company: GasLog Partners LP (GLOP)
Shares Offered: 4,000,000
More: offering details »

1/9/2018:
Company: AmpliPhi Biosciences Corporation (APHB)
Shares Offered: 4,000,000
More: offering details »

1/11/2018:
Company: Fortress Transportation and Infrastructure Investors LLC (FTAI)
Shares Offered: 7,000,000
More: offering details »

1/11/2018:
Company: Taylor Morrison Home Corporation (TMHC)
Shares Offered: 19,206,656
More: offering details »

1/16/2018:
Company: Inspired Entertainment, Inc. (INSE)
Shares Offered: 4,500,000
More: offering details »

1/16/2018:
Company: AveXis, Inc. (AVXS)
Shares Offered: 3,921,600
More: offering details »

1/16/2018:
Company: Keane Group, Inc. (FRAC)
Shares Offered: 13,321,753
More: offering details »

1/16/2018:
Company: Teekay Offshore Partners L.P. (TOO)
Shares Offered: 4,600,000
More: offering details »

1/16/2018:
Company: Sequans Communications S.A. (SQNS)
Shares Offered: 12,500,000
More: offering details »

1/16/2018:
Company: Obalon Therapeutics, Inc. (OBLN)
Shares Offered: 5,454,545
More: offering details »

1/16/2018:
Company: HTG Molecular Diagnostics, Inc. (HTGM)
Shares Offered: 12,100,000
More: offering details »

1/16/2018:
Company: BeiGene, Ltd. (BGNE)
Shares Offered: 7,425,750
More: offering details »

1/16/2018:
Company: New Residential Investment Corp. (NRZ)
Shares Offered: 25,000,000
More: offering details »

1/16/2018:
Company: Golden Entertainment, Inc. (GDEN)
Shares Offered: 6,500,000
More: offering details »

1/16/2018:
Company: Intrexon Corporation (XON)
Shares Offered: 6,000,000
More: offering details »

1/16/2018:
Company: Boot Barn Holdings, Inc. (BOOY)
Shares Offered: 6,000,000
More: offering details »

1/17/2018:
Company: UMH Properties, Inc. (UMH)
Shares Offered: 2,000,000
More: offering details »

1/17/2018:
Company: Arrowhead Pharmaceuticals Inc. (ARWR)
Shares Offered: 10,000,000
More: offering details »

1/17/2018:
Company: Agios Pharmaceuticals, Inc. (AGIO)
Shares Offered: 7,089,553
More: offering details »

1/17/2018:
Company: Paratek Pharmaceuticals, Inc. (PRTK)
Shares Offered: 3,205,128
More: offering details »

1/17/2018:
Company: Innovative Industrial Properties, Inc. (IIPR)
Shares Offered: 2,800,000
More: offering details »

1/18/2018:
Company: Jernigan Capital, Inc. (JCAP.PR.B)
More: offering details »

1/18/2018:
Company: Eagle Point Credit Company Inc. (ECC)
Shares Offered: 1,950,000
More: offering details »

1/18/2018:
Company: PAVmed Inc. (PAVM)
Shares Offered: 2,415,278
More: offering details »

1/18/2018:
Company: UroGen Pharma Ltd. (URGN)
Shares Offered: 1,463,414
More: offering details »

January 20, 2018    1:36 AM Eastern
Quotes delayed 20 minutes



Strong Buy (3.60 out of 4)
72nd percentile
(ranked higher than approx. 72% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2018, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.